Physical health of people with mental illness
Last updated:
Key points

People living with mental illness are more likely to experience poorer physical health than the general population.

People living with mental illness, and especially severe mental illness, tend to die earlier than the general population.

Almost 80% of premature deaths of people with mental illness are due to preventable physical health conditions.
People living with mental illness, and in particular severe mental illness (SMI), are more likely to experience comorbidity of physical conditions, more likely to be hospitalised for potentially preventable reasons and tend to die earlier than the general population (Sara et al. 2021; Lawrence et al. 2013).
For more information on mental illness, see the Prevalence and impact of mental illness.
Reporting on the physical health of people with mental illness
There is information on the prevalence of physical illness among people living with mental illness from population-based data sources, such as the Australian Bureau of Statistics (ABS) National Study of Mental Health and Wellbeing (NSMHW), National Health Survey (NHS) and Census of Population and Housing (the Census). One challenge in reporting on the physical health of people experiencing mental illness is a lack of consistent health systems data. Initiatives and programs that monitor the physical health of Australians with mental illness may provide insight, but they are not consistent across jurisdictions and different health settings.
How common is physical illness among people with mental illness?
According to the 2020–2022 NSMHW, an estimated 4.3 million Australians aged 16–85, or 22% of this population, had experienced a mental disorder in the 12 months prior to the study. Of these, 39% also had a long-term physical health condition. This represents an estimated 1.7 million people, or 8% of adults, experiencing both a mental illness and a long-term physical health condition (ABS 2023).
The 2021 Census results – which include people of all ages – found that people who reported having a mental illness were more likely to report also having another long-term health condition (Figure 1; ABS 2022b). Among the most common long-term conditions reported by those with a mental illness were arthritis, asthma and diabetes (Figure 1). Given the Census relies on people self-reporting long-term conditions, this is likely to be an underestimate as many people did not respond to this item, may not be aware that they have a long-term health condition or their mental illness did not satisfy the requirements of being considered long-term (that is, lasting 6 months or longer). For more information, view Chronic conditions and Multimorbidity.
Figure 1: Long-term health conditions reported by persons with and without mental illness in 2021
Bar chart showing percentages of people with and without a mental illness who reported long-term health conditions (excluding mental illness) in the 2021 Census.
| Selected long term health condition | Persons with a mental illness | Persons without mental illness |
|---|---|---|
| Arthritis | 19.0% | 8.2% |
| Asthma | 19.0% | 7.8% |
| Cancer | 4.7% | 3.0% |
| Diabetes | 8.6% | 4.8% |
| Heart disease | 7.0% | 4.0% |
| Kidney disease | 2.0% | 0.9% |
| Lung condition | 4.7% | 1.6% |
| Stroke | 2.2% | 0.9% |
| Any other long-term health condition(s) | 20.0% | 7.6% |
- Mental illness includes anxiety and depression.
- Diabetes excludes gestational diabetes; Cancer includes remission; Heart disease includes heart attack and angina; Lung condition includes Chronic obstructive pulmonary disease (COPD) or emphysema; Other long-term health condition(s) excludes dementia, Alzheimer’s disease and mental illness.
Source:
ABS 2022
A recent study of Australian general practice records examined the prevalence of physical health conditions and biomedical risk factors among people with severe mental illness (Belcher et al. 2021). Similarly, it showed a notable overlap between mental and physical illnesses. The prevalence of all surveyed biomedical risk factors was higher among patients with SMI than patients without. These included:
- dyslipidaemia (high cholesterol) (25% among those with SMI compared with 18% in patients without)
- hypertension (27% compared with 22%)
- obesity (29% compared with 19%).
The prevalence of all surveyed physical conditions was also higher among patients with SMI than patients without. These included:
- back pain (35% among those with SMI compared with 19% in patients without)
- cardiovascular disease (10% compared with 6.7%)
- gastro-oesophageal reflux disease (29% compared with 15%)
- arthritis (27% compared with 19%)
- cancer (19% compared with 15%).
Almost three-quarters (71%) of patients with SMI had at least one of the surveyed physical health conditions, compared with 54% of people without.
The second National Survey of People Living with Psychotic Illness includes estimates on the physical health of Australians living with a psychotic illness (Morgan et al. 2012). The prevalence of several physical conditions was higher among people with psychotic illness than people without. These included:
- chronic back, neck or other pain (32% among those with psychotic illness compared with 28% for the general population)
- asthma (30% compared with 20%)
- heart or circulatory conditions (27% compared with 16%).
In 2010, 24% of people with a psychotic illness were at high risk of cardiovascular disease, 45% were obese and 38% reported gaining weight as a medication side effect. Physical activity levels were markedly lower in people with a psychotic illness, with 96% classified as either sedentary or undertaking low levels of exercise in the previous week compared with 72% for the general population (Morgan et al. 2012).
Causes of physical illness among people with mental illness
Mental health is known to affect physical health and vice versa (Doan et al. 2023). For example, there is a long-established association between depression and heart disease. Multiple studies across various populations have shown that people with depression but no history of heart disease when the depression is assessed, are at markedly higher risk for coronary heart disease or cardiac mortality (Carney and Freedland 2003). Similarly, among patients who have just experienced a major cardiac event, such as a heart attack, those with depression are at an increased risk of another cardiac event or cardiac mortality compared to those without depression (Dhar and Barton 2016).
While the association between depression and coronary heart disease is well known, researchers have only recently begun to understand the biological mechanisms behind this relationship (Dhar and Barton 2016). Poor mental health can inhibit physical health behaviours – for example, it can lead to reduced physical activity or substance use as people try to self-medicate the symptoms of mental illness or psychological distress. Yet the reasons people with mental illness and especially SMI are more likely to experience poorer physical health and reduced life expectancy compared to the general population go beyond these mechanisms.
According to the Royal Australian and New Zealand College of Psychiatrists, the reasons people living with severe mental illness experience poorer physical health include:
- greater exposure to the known risk factors for physical disease such as lower socio-economic status, smoking, poor nutrition, reduced physical activity and higher sedentary behaviour
- reduced access to and quality of health care due to financial barriers, and stigma and discrimination among health care providers
- systemic issues in health care delivery, especially the separation of mental and physical health services, and a lack of clarity about who is responsible for monitoring the physical health of people with serious mental illness
- adverse effects of psychotropic medication, in particular their contribution to metabolic syndrome, obesity, cardiovascular disease and type 2 diabetes
- impacts from polypharmacy (the prescription of multiple medications) and prescribing practices
- lack of capability among both generalist and specialist health care staff to deal with complex comorbidities – mental health staff may lack skills, training and confidence to treat physical conditions and vice versa for physical health teams (RANZCP 2015).
For some people living with mental illness, symptoms may interfere with receiving medical care or compromise effective communication of physical symptoms with health care workers (Melamed et al. 2019).
In addition to poorer physical health and shorter life expectancy, higher rates of physical comorbidity among people with SMI can lead to higher levels of ongoing disability, reduced participation in the workforce and a greater likelihood of poverty and welfare dependency (RANZCP 2015).
Substance use can trigger or worsen mental health issues and is strongly associated with physical health conditions including cancer, cirrhosis, and cardiovascular disease (AIHW 2025). Among people living with mental illness, there are higher rates of alcohol, tobacco and other drug use compared with people without mental illness. For more information, see Alcohol, tobacco and other drug use in Australia – People with mental health conditions.
Substance use disorder (a type of mental disorder) is commonly associated with numerous physical health comorbidities as well as injuries from accidents, motor vehicle crashes and interpersonal violence (UNODC 2022). People living with substance use disorders are at increased risk of chronic illnesses such as cardiovascular disease, respiratory disorder and diabetes. As a population, this group:
- has higher rates of oral disease and nutritional deficiencies
- may suffer from comorbidities which are directly related to substance use (for example, cirrhosis of the liver from alcohol dependence or blood-borne virus from injecting drug use) (Osborne et al. 2022).
Chronic pain, sexually transmitted infections, and COVID-19 (due to underlying vulnerabilities) are also associated with substance use disorders (UNODC 2022). People with a substance use disorder experience reduced access to health services and neglect of physical health concerns may also contribute to physical comorbidities in this population (Osborne et al. 2022).
Comorbidity between substance use disorder and other kinds of mental disorders is common (Mills et al. 2019; Plana-Ripoll et al. 2019). Yet compared to literature looking at comorbidity of mental illness with substance use disorder, there is limited research available on physical comorbidities among people in treatment for substance use disorder (Osborne and Kelly 2023).
Life expectancy
Studies suggest that globally, the life expectancy of people with a mental illness is reduced compared with the general population (Chang et al. 2011; Momen et al. 2022; Plana-Ripoll et al. 2019; Walker et al. 2015). Research from Western Australia found that the gap in life expectancy for people with mental illness registered with West Australian mental health services compared with the general population in 2005 was 15.9 years for men and 12.0 years for women (Lawrence et al. 2013).
This research also indicated that the mortality gap for people living with mental illness had increased by 2.5 years for men and 1.6 years for women from 1985, with the increase largely driven by gains in life expectancy for the general population (Lawrence et al. 2013). This finding aligns with studies from other high-income countries suggesting that the mortality gap for people with mental illness may be increasing over time, in part due to gains in life expectancy for the general population not experienced (or at least not experienced in equal measure) by those with mental illness and especially SMI (Hayes et al. 2017; Laursen et al. 2019; Momen et al. 2022).
It is estimated that almost 80% of premature deaths of people with mental illness are due to potentially preventable physical health comorbidities such as type 2 diabetes, respiratory diseases, cancer and cardiovascular disease rather than as a direct result of mental illness or death by suicide (Lawrence et al. 2013). Compared with the general population, people with SMI have a 2- to 3-fold risk of developing hypertension and metabolic syndrome and, if under the age of 50, a 3-fold risk of dying from coronary heart disease (De Hert et al. 2009; Osborn et al. 2007). Furthermore, studies suggest that people who live with SMI and receive a cancer diagnosis experience higher rates of mortality compared to the general population (Charlesworth et al. 2023; Launders et al. 2022).
Substance use disorder is particularly associated with reduced life expectancy. A recent study has shown that substance use disorder has a profound negative impact on mortality and years of life lost following the onset of comorbid physical health conditions when compared with people with the same physical conditions, but no history of substance use disorder (Formanek et al. 2022). In 26 of the 28 physical health conditions surveyed, people with a history of hospitalisation for substance use disorder were more likely to die than their counterparts without this history (Formanek et al. 2022). People with mental illness are known to be at increased risk of premature mortality, but among all mental illness types, substance use disorder has been associated with the highest number of years of life lost (YLL) (Plana-Ripoll et al. 2019).
While mental illness is associated with poorer health outcomes and a reduced life expectancy, comorbid substance use disorder alongside other mental disorders is associated with markedly higher mortality rates and larger reductions in life expectancy (Plana-Ripoll et al. 2020). For more information on comorbidity of substance use disorders and other mental illness, view Mental health and substance use.
A number of data sources have indicated impacts on both the mental and physical health of Australians during the pandemic. As in other parts of the world, the pandemic and related restrictions had significant impacts on the mental health of Australians. Multiple sources of data indicated increased and more widespread psychological distress compared with pre-pandemic levels and increased use of mental health services and mental health prescriptions (ABS 2022a; Biddle and Gray 2021; Butterworth 2020). Those aged 18–35, women, people with a disability, renters, and people who report having a mental health condition were more likely to report high or very high levels of psychological distress (ABS 2022a).
Despite modifications and additions to health service delivery models during the pandemic (for example, telehealth consultations), many people delayed access to health care which can lead to acute and long-term health consequences (White et al. 2021). Issues included restrictions on movement during lockdowns, fear of contracting COVID-19, fear of overburdening the health system, financial stress and disruptions to elective surgery and other health services. Notably, people experiencing high levels of psychological distress were 6 times more likely to choose not to consult a health professional when needed than those who were not (Zhang et al. 2020).
For people living with SMI – a group which generally has less access to health care – pandemic-related restrictions may have worsened physical health (Melamed et al. 2020). People with SMI were already overrepresented in acute physical health care episodes in hospitals prior to the pandemic, therefore the burden placed on acute health care settings from the pandemic may have disproportionally affected this group (Melamed et al. 2020; Sara et al. 2021).
Future directions
Data linkage, for example through the National Health Data Hub may provide further insights into the relationships between mental illness, physical comorbidities and mortality among the Australian population. While separate data collections provide a limited view on peoples’ overall health, data linkage allows for analysis of the impact of mental illness on physical health conditions from across different service settings and types of service usage. This data could assist in identifying areas of disadvantage in broader health settings and barriers to service usage for people with mental illness, which is critical as this population group accesses health services at a lower rate than the general population.
Where can I find more information?
For more information on the physical health of people with mental illness, see:
- Equally Well: Improving the physical health of people living with mental illness
- Victoria University: Being equally well roadmap
- The Royal Australian & New Zealand College of Psychiatrists: Expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness
- Mental health and substance use
ABS (Australian Bureau of Statistics) (2022a) Household Impacts of COVID-19 Survey, September 2022, ABS, Australian Government, accessed 21 March 2025.
ABS (2022b) Type of Long-term Health Condition (LTHP) by Whether has Mental Health Condition (HMHCP) [Census Table Builder], accessed 6 February 2023.
ABS (2023) National study of mental health and wellbeing, 2020-22: Summary of results, ABS, Australian Government, accessed 21 March 2025.
AIHW (Australian Institute of Health and Welfare) (2025) Alcohol, tobacco & other drugs in Australia: Health Impacts, AIHW, Australian Government, accessed 21 March 2025.
Belcher J, Myton R, Yoo J, Boville C and Chidwick K (2021) ‘Exploring the physical health of patients with severe or long-term mental illness using routinely collected general practice data from MedicineInsight’,Australian Journal of General Practice, 50(12):944–949, accessed 21 March 2025, doi:10.31128/AJGP-08-20-5563.
Biddle N and Gray M (2021) ‘Tracking wellbeing outcomes during the COVID-19 pandemic (October 2021): Putting the worst behind us?’, Australian National University, accessed 21 March 2025.
Butterworth P (2020) Research Insight 6/20 How to protect mental health through the COVID-19 crisis?, University of Melbourne, accessed 21 March 2025.
Carney RM and Freedland KE (2003) ‘Depression, mortality, and medical morbidity in patients with coronary heart disease’, Biological Psychiatry, 54(3):241-247, accessed 21 March 2025.doi: 10.1016/s0006-3223(03)00111-2.
Chang CK, Hayes RD, Perera G, Broadbent MTM, Fernandes AC, Lee WE, Hotopf, M and Stewart R (2011) ‘Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London’ PLoS ONE, 6(5): e19590, accessed 21 March 2025, doi: 10.1371/journal.pone.0019590
Charlesworth L, Fegan C and Ashmore R (2023) ‘How does severe mental illness impact on cancer outcomes in individuals with severe mental illness and cancer? A scoping review of the literature,’ Journal of Medical Imaging and Radiation Sciences, 54(2S): S104-S114, accessed 21 March 2025, doi:10.1016/j.jmir.2023.01.007.
De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI and Möller HJ (2009) ‘Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)’, European Psychiatry, 24(6):412-24, accessed 21 March 2025, doi: 10.1016/j.eurpsy.2009.01.005.
Doan T, Ha V, Strazdins L and Chateau D (2023) ‘Healthy minds live in healthy bodies – effect of physical health on mental health: Evidence from Australian longitudinal data’, Current Psychology, 42: 18702–18713, accessed 21 March 2025, doi.org/10.1007/s12144-022-03053-7
Dhar AK and Barton DA (2016). ‘Depression and the link with cardiovascular disease’, Front Psychiatry, 7:33, accessed 21 March 2025, doi: 10.3389/fpsyt.2016.00033.
Formánek T, Krupchanka D, Mladá K, Winkler P, Jones PB (2022) ‘Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia’, Lancet Psychiatry, 9(12):957-968, accessed 21 March 2025, doi: 10.1016/S2215-0366(22)00335-2.
Hayes JF, Marston L, Walters K, King MB and Osborn DPJ (2017) ‘Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014’, British Journal of Psychiatry, 211(3):175-181, accessed 21 March 2025, doi: 10.1192/bjp.bp.117.202606.
Launders N, Scolamiero L, Osborn DPJ and Hayes JF (2022) ‘Cancer rates and mortality in people with severe mental illness: Further evidence of lack of parity’, Schizophr Res. 246:260-267, doi, accessed 21 March 2025, 10.1016/j.schres.2022.07.008.
Laursen TM, Plana-Ripoll O, Andersen PK, McGrath JJ, Toender A, Nordentoft M, Canudas-Romo V and Erlangsen A (2019) ‘Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse?’ Schizophr Res, 206:284-290, accessed 21 March 2025, doi: 10.1016/j.schres.2018.11.003.
Lawrence D, Hancock K and Kisely S (2013) ‘The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers’, British Medical Journal, 346, accessed 21 March 2025, doi:10.1136/bmj.f2539.
Melamed OC, Fernando I, Soklaridis S, Hahn MK, LeMessurier KW and Taylor VH (2019);‘ Understanding engagement with a physical health service: A qualitative study of patients with severe mental illness', Can J Psychiatry, 64(12):872-880, accessed 21 March 2025, doi: 10.1177/0706743719862980.
Melamed OC, Hahn MK, Agarwal SM, Taylor VH, Mulsant BH and Selby P (2020) ‘Physical health among people with serious mental illness in the face of COVID-19: Concerns and mitigation strategies’, Gen Hosp Psychiatry, 66:30-33, accessed 21 March 2025, doi: 10.1016/j.genhosppsych.2020.06.013.
Mills K, Marel C, Madden E and Teesson M (2019) Lessening the burden of comorbid substance use and mental disorders through evidence-based care: The case for a National Minimum Qualifications Strategy. Submission to the Australian Government Productivity Commission Mental Health Inquiry, Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, accessed 21 March 2025.
Momen NC, Plana-Ripoll O, Agerbo E, Christensen MK, Iburg KM, Laursen TM, Mortensen PB, Pedersen CB, Prior A, Weye N and McGrath JJ (2022) ‘Mortality associated with mental disorders and comorbid general medical conditions’ JAMA Psychiatry. 79(5):444–453, accessed 21 March 2025, doi:10.1001/jamapsychiatry.2022.0347
Morgan VA, Waterreus A, Jablensky A, Mackinnon A, McGrath JJ, Carr V, Bush R, Castle D, Cohen M, Harvey C, Galletly C, Stain HJ, Neil AL, McGorry P, Hocking B, Shah S and Saw S (2012) ‘People living with psychotic illness 2010: The second Australian national survey’ Aust N Z J Psychiatry, 46(8):735-52, accessed 21 March 2025, doi: 10.1177/0004867412449877.
Osborn DPJ, Levy G, Nazareth I, Petersen I, Islam A and King MB (2007) ‘Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database’, Arch Gen Psychiatry, 64(2):242–249, accessed 21 March 2025, doi:10.1001/archpsyc.64.2.242.
Osborne B and Kelly PJ (2023) ‘Substance use disorders, physical health and recovery capital: Examining the experiences of clients and the alcohol and other drug workforce’, Drug Alcohol Rev, 42(6):1410-1421, accessed 21 March 2025, doi: 10.1111/dar.13689.
Osborne B, Larance B, Ivers R, Deane FP, Robinson LD, Kelly PJ (2022) ‘Systematic review of guidelines for managing physical health during treatment for substance use disorders: Implications for the alcohol and other drug workforce’, Drug Alcohol Rev, 41(6):1367-1390, accessed 21 March 2025, doi: 10.1111/dar.13504.
Plana-Ripoll O, Pedersen CB, Agerbo E, Holtz Y, Erlangsen A, Canudas-Romo V, Andersen PK, Charlson FJ, Christensen MK, Erskine HE, Ferrari AJ, Iburg KM, Momen N, Mortensen PB, Nordentoft M, Santomauro DF, Scott JG, Whiteford HA, Weye N, McGrath JJ and Laursen TM (2019) ‘A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study’, Lancet, 394(10211):1827-1835, accessed 21 March 2025, doi: 10.1016/S0140-6736(19)32316-5.
Plana-Ripoll O, Musliner KL, Dalsgaard S, Momen NC, Weye N, Christensen MK, Agerbo E, Iburg KM, Laursen TM, Mortensen PB, Pedersen CB, Petersen LV, Santomauro DF, Vilhjálmsson BJ, Whiteford HA and McGrath JJ (2020) ‘Nature and prevalence of combinations of mental disorders and their association with excess mortality in a population-based cohort study’, World Psychiatry 19(3):339-349, accessed 21 March 2025, doi: 10.1002/wps.20802.
RANZCP (Royal Australian and New Zealand College of Psychiatrists) (2015) Keeping body and mind together: Improving the physical health and life expectancy of people with serious mental illness, A report prepared for the Royal Australian and New Zealand College of Psychiatrists, RANZCP, accessed 21 March 2025.
Sara G, Chen W, Large M, Ramanuj P, Curtis J, McMillan F, Mulder CL, Currow D and Burgess P (2021) ‘Potentially preventable hospitalisations for physical health conditions in community mental health service users: a population-wide linkage study’, Epidemiology and Psychiatric Sciences, 30(e22):1-10, accessed 21 March 2025, doi: 10.1017/S204579602100007X.
UNODC (United Nations Office on Drugs and Crime) (2022) Comorbidities in drug use disorders: No wrong door Discussion paper, UN, accessed 21 March 2025.
Walker ER, McGee RE and Druss BG (2015) ‘Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis’, JAMA Psychiatry, 72(4):334–341, accessed 21 March 2025, doi:10.1001/jamapsychiatry.2014.2502.
White J, Cavenagh D, Byles J, Mishra G, Tooth L and Loxton D (2021) ’The experience of delayed health care access during the COVID 19 pandemic in Australian women: A mixed methods exploration ’, Health & Social Care in the Community, 00:1–12, accessed 21 March 2025, doi:10.1111/hsc.13546.
Zhang Y, Liu J and Scott A (2020) Research Insight 23/20: Using health care during the pandemic: Should I stay or should I go? University of Melbourne, accessed 15 March 2022.